In This Article:
NEW YORK, NY / ACCESSWIRE / April 20, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
TVTY Shareholders Click Here: https://www.zlk.com/pslra-1/tivity-health-inc-loss-form?prid=6102&wire=1
ALGN Shareholders Click Here: https://www.zlk.com/pslra-1/align-technology-inc-loss-form-2?prid=6102&wire=1
INO Shareholders Click Here: https://www.zlk.com/pslra-1/inovio-pharmaceuticals-inc-loss-form?prid=6102&wire=1
* ADDITIONAL INFORMATION BELOW *
Tivity Health, Inc. (TVTY)
TVTY Lawsuit on behalf of: investors who purchased March 8, 2019 - February 19, 2020
Lead Plaintiff Deadline : April 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tivity-health-inc-loss-form?prid=6102&wire=1
According to the filed complaint, during the class period, Tivity Health, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) following the Nutrisystem Acquisition, Tivity's Nutrition segment faced significant operational challenges; (ii) the foregoing would foreseeably have a significant impact on Tivity's revenues; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Align Technology, Inc. (ALGN)
ALGN Lawsuit on behalf of: investors who purchased April 24, 2019 - July 24, 2019
Lead Plaintiff Deadline : May 1, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/align-technology-inc-loss-form-2?prid=6102&wire=1
According to the filed complaint, during the class period, Align Technology, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) Align was then experiencing a significant decline in demand for its products in the important Chinese market; (b) Chinese consumer sentiment towards the Company was deteriorating; and (c) as a result of the foregoing, Defendants' positive statements about Align and its businesses were lacking in a reasonable basis.
Inovio Pharmaceuticals, Inc. (INO)
INO Lawsuit on behalf of: investors who purchased February 14, 2020 - March 9, 2020
Lead Plaintiff Deadline : May 12, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/inovio-pharmaceuticals-inc-loss-form?prid=6102&wire=1
According to a filed complaint, throughout the class period, defendants made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.